Concepedia

Robert J. Kinders

RJ

79

Publications

5.2K

Citations

39

H-Index

1979

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

Frederick National Laboratory for Cancer Research

Leidos (United States)

Science Applications International Corporation (United States)

Robert J. Kinders is an author at National Cancer Institute specializing in medicine, cancer research, and oncology.

ORCID

Top concepts

Publications per year

1979–2023

79

Publications

79

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 324 citations · Full text

Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors

T. Khanh, Deborah Wilsker, Jiuping Ji et al. · Journal of Clinical Oncology · 2015 · 317 citations · Full text

Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas

Shivaani Kummar, Alice P. Chen, Jiuping Ji et al. · Cancer Research · 2011 · 252 citations

Cediranib for Metastatic Alveolar Soft Part Sarcoma

Shivaani Kummar, Deborah Allen, Anne Monks et al. · Journal of Clinical Oncology · 2013 · 217 citations

A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

Shivaani Kummar, Jiuping Ji, Robert J. Morgan et al. · Clinical Cancer Research · 2012 · 201 citations · Full text

Rows per page

1–5 of 79